Due to an error in the preparation of [Figure 5B](#pone-0108710-g001){ref-type="fig"}, two of the panels in this figure are incorrect: The \"Total JNK\" panel for BxPC-3 cells (right) incorrectly duplicates the \"Total JNK\" panel for AsPC-1 cells (left) The \"p-ERK1/2\" panel for the BxPC-3 cells (right) incorrectly displays the \"p-ERK1/2\" panel for AsPC-1 cells (left). The authors apologize for these mistakes and are supplying a corrected [Figure 5](#pone-0108710-g001){ref-type="fig"} and the raw blots for this figure. These errors do not affect the results and conclusions reported in the article.

![Knockdown of MKP2 does not affect JNK/p38 MAPK signaling activity or pancreatic cancer chemosensitivity to gemcitabine.\
AsPC-1 and BxPC-3 cells were stably transduced with lentivirus expressing shRNA against scramble control or MKP2. (A) Cells were incubated for 48 h in the absence or presence of varying concentrations of gemcitabine, and MTT assays were performed. (B) AsPC-1 and BxPC-3 cells were incubated for the indicated times with 100 ng/ml and 10 ng/ml gemcitabine, respectively, and immunoblotting was conducted. Data are the means ± SEM of 3 experiments.](pone.0108710.g001){#pone-0108710-g001}
